Paragon 28 Aktie [WKN DE: A3C5FT / ISIN: US69913P1057]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Paragon 28 Inc Registered Shs

11.12.24		Paragon 28 Appoints Dave Demski to Board of Directors (Businesswire)
29.11.24		ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28 (Businesswire)
18.11.24		Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference (Businesswire)
17.10.24		Paragon 28 To Report Third Quarter 2024 Financial Results on November 12, 2024 (Businesswire)
16.10.24		Paragon 28 Launches the Phantom® Fibula Nail System for Less Invasive Fracture Repair (Businesswire)
10.09.24		Paragon 28 Introduces a Novel Right-Angle Drill for the APEX 3D™ Total Ankle Replacement System (Businesswire)
04.09.24		Paragon 28 Launches the R3FLEX™ Stabilization System to Anatomically Repair Ankle Syndesmotic Injuries (Businesswire)
17.07.24		Paragon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024 (Businesswire)
08.05.24		Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance (Businesswire)
02.05.24		Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference (Businesswire)
04.04.24		Paragon 28 CFO Stephen Deitsch Resigns; Names Interim Replacement; Backs Annual Revenue Outlook (RTTNews)
04.04.24		Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024 (Businesswire)
28.03.24		Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System (Businesswire)
29.02.24		Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance (Businesswire)
12.02.24		Paragon 28 to Present at the CG 2024 Musculoskeletal Conference (Businesswire)
06.02.24		Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 (Businesswire)
01.02.24		Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions (Businesswire)
30.01.24		Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures (Businesswire)
26.01.24		Paragon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures (Businesswire)
17.01.24		Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures (Businesswire)
08.01.24		Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 (Businesswire)
05.01.24		Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape (Businesswire)
19.12.23		Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Businesswire)
14.11.23		Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio (Businesswire)
14.11.23		Paragon 28 Launches JAWS™ Great White Staple System Further Expanding its Nitinol Staple Offering (Businesswire)
13.11.23		Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program (Businesswire)
07.11.23		Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance (Businesswire)
07.11.23		Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility (Businesswire)
03.11.23		Paragon 28 to Present at Upcoming Investor Conferences (Businesswire)
17.10.23		Paragon 28 To Report Third Quarter Financial Results on November 7, 2023 (Businesswire)
11.09.23		Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System (Businesswire)
28.08.23		Paragon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (Businesswire)
02.08.23		Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance (Businesswire)
28.07.23		Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference (Businesswire)
12.07.23		Paragon 28 To Report Second Quarter Financial Results on August 2, 2023 (Businesswire)
23.05.23		Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System (Businesswire)
04.05.23		Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance (Businesswire)
26.04.23		Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference (Businesswire)
24.04.23		Paragon 28 Launches Phantom® Metatarsal Shortening System (Businesswire)
20.04.23		Paragon 28 To Report First Quarter Financial Results on May 4, 2023 (Businesswire)
02.03.23		Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance (Businesswire)
01.03.23		Paragon 28 to Present at Upcoming Investor Conferences (Businesswire)
17.02.23		Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock (Businesswire)
16.02.23		Paragon 28 To Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 (Businesswire)
26.01.23		Paragon 28, Inc. Announces Pricing of Public Offering (Businesswire)
25.01.23		Paragon 28, Inc. Announces Proposed Public Offering of Common Stock (Businesswire)
10.01.23		Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022 (Businesswire)
16.11.22		Paragon 28 to Present at The 34th Annual Piper Sandler Healthcare Conference (Businesswire)
10.11.22		Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance (Businesswire)
27.10.22		Paragon 28 To Report Third Quarter 2022 Financial Results on November 10, 2022 (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Solana Kurs Prognose: Support bei 180 US-Dollar hält! Jetzt einsteigen und Millionär werden?

Pierer Mobility-Aktie mit zweistelligem Kurssprung: KTM AG wird fortgeführt - Eigenverwaltung bleibt

Bitcoin über 100.000 US-Dollar: Lohnt sich der Einstieg für Anleger jetzt noch?

RBI-Aktie tiefer: RBI droht Milliarden-Zahlung im Streit mit Russland

Banque Syz prognostiziert Überraschungen für 2025: Musk-Meloni-Hochzeit und das Ende der Musk-Trump-Verbindung

Crash oder Rally: Das sind die Experten-Prognosen für Kryptowährungen wie Bitcoin, Ethereum & Co. im Jahr 2025

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	23.12.2024 08:51
Kaufwert:	EUR
	Hinzufügen Speichern